Director, Health Eco and Outcomes Research
Alkermes
2 hours ago
Remote friendly (Greater Boston)
United States
$240,000 - $254,000 USD yearly
Market Access
Responsibilities:
- Execute on the HEOR plan for the alixorexton program (Phase 2 advancing to Phase 3 and potential registration), including patient populations: narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH)
- Identify and address evidence gaps and prioritize real-world studies to inform treatment patterns, disease burden, patient-reported outcomes, and unmet needs
- Develop and deliver high-quality HEOR evidence and value communication strategies to support optimal access and reimbursement
- Gather and synthesize insights from payers, healthcare professional thought leaders, and HEOR experts
- Collaborate on publication strategies; disseminate evidence via conference presentations and peer-reviewed manuscripts
- Select and manage external research partners to ensure high-quality, timely study delivery
Experience (related):
- Developing budget impact models (BIMs) and cost-effectiveness analyses (CEAs)
- Conducting indirect treatment comparisons (ITCs)
- Developing AMCP Dossiers and pre-approval information exchange (PIE) slide decks
- Real-world evidence (RWE) generation (e.g., natural history, burden of illness, treatment patterns) using claims, EHR, registries, chart reviews, and qualitative research
Qualifications:
- Basic Requirements: MA/MS in HEOR/related field with 8+ years pharma HEOR experience (direct research preferred) OR PhD/PharmD in HEOR/related field with 5+ years similar experience
- Preferred: Strong high-impact peer-reviewed publications; excellent communication/presentation/collaboration; experience supporting a competitive product launch; experience in rare disease/neurological/sleep-wake disorders (plus); excellent project management
- Execute on the HEOR plan for the alixorexton program (Phase 2 advancing to Phase 3 and potential registration), including patient populations: narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH)
- Identify and address evidence gaps and prioritize real-world studies to inform treatment patterns, disease burden, patient-reported outcomes, and unmet needs
- Develop and deliver high-quality HEOR evidence and value communication strategies to support optimal access and reimbursement
- Gather and synthesize insights from payers, healthcare professional thought leaders, and HEOR experts
- Collaborate on publication strategies; disseminate evidence via conference presentations and peer-reviewed manuscripts
- Select and manage external research partners to ensure high-quality, timely study delivery
Experience (related):
- Developing budget impact models (BIMs) and cost-effectiveness analyses (CEAs)
- Conducting indirect treatment comparisons (ITCs)
- Developing AMCP Dossiers and pre-approval information exchange (PIE) slide decks
- Real-world evidence (RWE) generation (e.g., natural history, burden of illness, treatment patterns) using claims, EHR, registries, chart reviews, and qualitative research
Qualifications:
- Basic Requirements: MA/MS in HEOR/related field with 8+ years pharma HEOR experience (direct research preferred) OR PhD/PharmD in HEOR/related field with 5+ years similar experience
- Preferred: Strong high-impact peer-reviewed publications; excellent communication/presentation/collaboration; experience supporting a competitive product launch; experience in rare disease/neurological/sleep-wake disorders (plus); excellent project management